IP Library › Granted Patent US 7,761,155
Granted Patent B2
US 7,761,155 · App. 11/675,312 · Granted Jul 20, 2010

Method and device for delivering anti-tachycardia pacing therapy

Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,761,155
App. No.
11/675,312
Granted
Jul 20, 2010
Kind
B2
Abstract

A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy. The processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event, and adjusts delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause.

Claims (75)

1. A method for delivering a therapy to terminate a tachycardia event, comprising:

sensing cardiac signals and detecting the tachycardia event in response to the sensed cardiac signals;

delivering a first plurality of pacing pulses in response to the detected cardiac event;

determining a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event by considering at least two of the failure to capture the tachycardia event, the failure to complete peelback, and the failure to entrain a reentrant circuit associated with the tachycardia event; and

adjusting delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause.

2. The method of claim 1 , wherein the determining a cause comprises:

determining a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses; and

determining whether the return cycle length is less than or equal to a cycle length associated with the tachycardia event.

3. The method of claim 1 , wherein the determining a cause comprises:

determining a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses; and

determining whether the return cycle length is greater than or equal to a sum of a cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses.

4. The method of claim 1 , wherein the determining comprises:

determining a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses; and

determining whether the return cycle length is greater than a cycle length associated with the tachycardia event and less than a sum of the cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses.

5. The method of claim 1 , further comprising determining a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event.

6. A method for delivering a therapy to terminate a tachycardia event, comprising:

sensing cardiac signals and detecting the tachycardia event in response to the sensed cardiac signals;

delivering a first plurality of pacing pulses in response to the detected cardiac event;

determining a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

adjusting delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause;

further comprising determining a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event; and

wherein the transit time is determined as one half of a difference between the return cycle length and the cycle length associated with the tachycardia event.

7. A method for delivering a therapy to terminate a tachycardia event, comprising:

sensing cardiac signals and detecting the tachycardia event in response to the sensed cardiac signals;

delivering a first plurality of pacing pulses in response to the detected cardiac event;

determining a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

adjusting delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause further comprising determining a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event; and

further comprising determining a minimum number of pacing pulses to enable delivery of the second plurality of pacing pulses to reach the reentrant circuit in response to the determined transit time.

8. A method for delivering a therapy to terminate a tachycardia event, comprising:

sensing cardiac signals and detecting the tachycardia event in response to the sensed cardiac signals;

delivering a first plurality of pacing pulses in response to the detected cardiac event;

determining a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

adjusting delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause;

determining a cycle length of each pacing pulse of the second plurality of pacing pulses; and

determining prematurities associated with the second plurality of pacing pulses as a difference between the cycle length of each pacing pulse of the second plurality of pacing pulses and the cycle length associated with the tachycardia event.

9. The method of claim 8 , further comprising:

determining a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event; and

determining a minimum number of pacing pulses to enable delivery of the second plurality of pacing pulses to reach the reentrant circuit in response to the determined transit time and the prematurities.

10. A method for delivering a therapy to terminate a tachycardia event, comprising:

sensing cardiac signals and detecting the tachycardia event in response to the sensed cardiac signals;

delivering a first plurality of pacing pulses in response to the detected cardiac event;

determining a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event; and

adjusting delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause;

wherein the adjusting comprises:

decreasing a prematurity associated with the second plurality of pacing pulses in response to the cause being determined as a failure to capture the tachycardia event;

increasing a total prematurity associated with the second plurality of pacing pulses in response to the cause being determined as a failure to complete peelback; and

increasing a prematurity of at least one pacing pulse of the second plurality of pacing pulses in response to the cause being determined as a failure to entrain a reentrant circuit associated with the tachycardia event.

11. A medical device for delivering a therapy to terminate a tachycardia event, comprising:

an electrode to sense cardiac signals and to deliver the therapy, the therapy including a first plurality of pacing pulses;

sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals; and

a processor to control delivery of the therapy, wherein the processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event by considering at least two of the failure to capture the tachycardia event, the failure to complete peelback, and the failure to entrain a reentrant circuit associated with the tachycardia event, and adjusts delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause.

12. The device of claim 11 , wherein the processor determines a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses, and whether the return cycle length is less than or equal to a cycle length associated with the tachycardia event.

13. The device of claim 11 , wherein the processor determines a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses, and whether the return cycle length is greater than or equal to a sum of a cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses.

14. The device of claim 11 , wherein the processor determines a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses, and whether the return cycle length is greater than a cycle length associated with the tachycardia event and less than a sum of the cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses.

15. The device of claim 11 , wherein the processor determines a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event.

16. The device of claim 15 , wherein the processor determines a minimum number of pacing pulses to enable delivery of the second plurality of pacing pulses to reach the reentrant circuit in response to the determined transit time.

17. A medical device for delivering a therapy to terminate a tachycardia event, comprising:

an electrode to sense cardiac signals and to deliver the therapy, the therapy including a first plurality of pacing pulses;

sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals; and

a processor to control delivery of the therapy, wherein the processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

wherein the processor determines a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event;

wherein the transit time is determined as one half of a difference between the return cycle length and the cycle length associated with the tachycardia event.

18. A medical device for delivering a therapy to terminate a tachycardia event, comprising:

an electrode to sense cardiac signals and to deliver the therapy, the therapy including a first plurality of pacing pulses;

sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals; and

a processor to control delivery of the therapy, wherein the processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

wherein the processor determines a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event;

wherein the processor determines a cycle length of each pacing pulse of the second plurality of pacing pulses, and determines prematurities associated with the second plurality of pacing pulses as a difference between the cycle length of each pacing pulse of the second plurality of pacing pulses and the cycle length associated with the tachycardia event.

19. The device of claim 18 , wherein the processor determines a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event, and determines a minimum number of pacing pulses to enable delivery of the second plurality of pacing pulses to reach the reentrant circuit in response to the determined transit time and the prematurities.

20. A medical device for delivering a therapy to terminate a tachycardia event, comprising:

an electrode to sense cardiac signals and to deliver the therapy, the therapy including a first plurality of pacing pulses;

sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals; and

a processor to control delivery of the therapy, wherein the processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event;

wherein the processor determines a transit time corresponding to a distance between the electrode and the reentrant circuit associated with the tachycardia event;

wherein the processor decreases a prematurity associated with the second plurality of pacing pulses in response to the cause being determined as a failure to capture the tachycardia event, increases a total prematurity associated with the second plurality of pacing pulses in response to the cause being determined as a failure to complete peelback, and increases a prematurity of at least one pacing pulse of the second plurality of pacing pulses in response to the cause being determined as a failure to entrain a reentrant circuit associated with the tachycardia event.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2007
From: BELK, PAUL A.; JACKSON, TROY E.
To: MEDTRONIC, INC.
Reel/Frame 018894/0817 →
Continuity (2)
Provisional Application 6077348300 · Feb 15, 2006
Related Publication 20070191900A1 · Aug 16, 2007